
Novelos News
February 4, 2013
NOVELOS THERAPEUTICS TO PRESENT AT THE 15th ANNUAL BIO CEO & INVESTOR CONFERENCE ON FEBRUARY 11
January 31, 2013
NOVELOS THERAPEUTICS PRESENTS DIAPEUTIC TECHNOLOGY PLATFORM AT EMIT: TARGETED RADIOTHERAPY INTERNATIONAL CONFERENCE
November 27, 2012
NOVELOS THERAPEUTICS TO PRESENT AT THE BENCHMARK 2012 MICRO CAP DISCOVERY INVESTOR CONFERENCE ON NOVEMBER 29
October 3, 2012
NOVELOS THERAPEUTICS AND ACADEMIC COLLABORATORS PRESENT DIAPEUTIC TECHNOLOGY PLATFORM AT IMAGING IN 2020 CONFERENCE
September 11, 2012
NOVELOS THERAPEUTICS SUCCESSFULLY COMPLETES SECOND COHORT IN PHASE 1b SOLID TUMOR TRIAL WITH I-131-CLR1404 (HOT) CANCER-TARGETED MOLECULAR RADIOTHERAPEUTIC
September 7, 2012
NOVELOS THERAPEUTICS AND ACADEMIC COLLABORATORS PRESENT THREE POSTERS AT 2012 WORLD MOLECULAR IMAGING CONGRESS
September 4, 2012
NOVELOS THERAPEUTICS TO PRESENT AT RODMAN & RENSHAW 14th ANNUAL HEALTHCARE CONFERENCE ON SEPTEMBER 11
August 28, 2012
NOVELOS THERAPEUTICS DEVELOPING CLR1502 (GLOW2) CANCER-TARGETED OPTICAL IMAGING AGENT FOR INTRAOPERATIVE TUMOR MARGIN ILLUMINATION
June 27, 2012
